We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-2 of 2

News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • June 21 2012

The Food and Drug Administration seeks comments by August 13, 2012, on draft and revised draft guidances for industry describing product-specific bioequivalence recommendations regarding the design of studies to support abbreviated new drug applications.